Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-25-025767
Filing Date
2025-08-08
Accepted
2025-08-08 17:08:01
Documents
19
Period of Report
2025-08-28

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A wint20250801_def14a.htm   iXBRL DEF 14A 753763
6 image1.jpg GRAPHIC 9144
7 internet.jpg GRAPHIC 2835
8 mail.jpg GRAPHIC 1696
9 meeting.jpg GRAPHIC 2036
10 wt_page1.jpg GRAPHIC 324512
11 wt_page2.jpg GRAPHIC 220848
  Complete submission text file 0001437749-25-025767.txt   2584335

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA wint-20241231.xsd EX-101.SCH 4578
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20241231_def.xml EX-101.DEF 1750
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20241231_lab.xml EX-101.LAB 1775
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20241231_pre.xml EX-101.PRE 714
21 EXTRACTED XBRL INSTANCE DOCUMENT wint20250801_def14a_htm.xml XML 1183
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39290 | Film No.: 251199345
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)